Loading...
iSpecimen Inc.
ISPC•NASDAQ
Healthcare
Medical - Diagnostics & Research
$1.07
$-0.03(-2.73%)
iSpecimen Inc. (ISPC) Financial Performance & Income Statement Overview
Review iSpecimen Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-6.42%
↓ 6.42%
Operating Income Growth
-13.96%
↓ 13.96%
Net Income Growth
-12.60%
↓ 12.60%
Operating Cash Flow Growth
-42.29%
↓ 42.29%
Operating Margin
-141.04%
↓ 141.04%
Gross Margin
30.92%
↑ 30.92%
Net Profit Margin
-139.65%
↓ 139.65%
ROE
-285.21%
↓ 285.21%
ROIC
-590.90%
↓ 590.90%
iSpecimen Inc. (ISPC) Income Statement & Financial Overview
Review iSpecimen Inc.'s (ISPC) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.48M | $2.66M | $2.86M | $2.29M |
| Cost of Revenue | $1.32M | $1.55M | $2.03M | $1.60M |
| Gross Profit | $151352.00 | $1.11M | $832543.00 | $693298.00 |
| Gross Profit Ratio | $0.10 | $0.42 | $0.29 | $0.30 |
| R&D Expenses | $951667.00 | $0.00 | $1.05M | $1.11M |
| SG&A Expenses | $6.22M | $1.52M | $1.96M | $2.58M |
| Operating Expenses | $5.99M | $2.81M | $3.01M | $3.69M |
| Total Costs & Expenses | $7.32M | $4.37M | $5.05M | $5.29M |
| Interest Income | $3237.00 | $1235.00 | $9163.00 | $30498.00 |
| Interest Expense | $203771.00 | $7364.00 | $4474.00 | $4465.00 |
| Depreciation & Amortization | $548036.00 | $542779.00 | $606744.00 | $596689.00 |
| EBITDA | -$5.30M | -$889710.00 | -$1.50M | -$2.30M |
| EBITDA Ratio | -$3.59 | -$0.33 | -$0.52 | -$1.005 |
| Operating Income | -$5.84M | -$1.71M | -$2.18M | -$3.001M |
| Operating Income Ratio | -$3.96 | -$0.64 | -$0.76 | -$1.31 |
| Other Income/Expenses (Net) | -$206355.00 | $265551.00 | $72641.00 | $98403.00 |
| Income Before Tax | -$6.05M | -$1.44M | -$2.11M | -$2.90M |
| Income Before Tax Ratio | -$4.10 | -$0.54 | -$0.74 | -$1.27 |
| Income Tax Expense | $0.00 | $0.00 | -$4.00 | $0.00 |
| Net Income | -$6.05M | -$1.44M | -$2.11M | -$2.90M |
| Net Income Ratio | -$4.10 | -$0.54 | -$0.74 | -$1.27 |
| EPS | -$8.51 | -$2.10 | -$3.72 | -$6.36 |
| Diluted EPS | -$8.51 | -$2.10 | -$3.72 | -$6.36 |
| Weighted Avg Shares Outstanding | $963227.00 | $687141.00 | $567029.00 | $456623.00 |
| Weighted Avg Shares Outstanding (Diluted) | $963227.00 | $687141.00 | $567029.00 | $456623.00 |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan